Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma (GEM) Study.
Miles JA, Orlow I, Kanetsky PA, Luo L, Cust AE, Armstrong BK, Kricker A, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Gibbs DC, Busam KJ, Mavinkurve V, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group. Miles JA, et al. Among authors: orlow i. J Invest Dermatol. 2019 Jun;139(6):1410-1412. doi: 10.1016/j.jid.2018.11.030. Epub 2018 Dec 17. J Invest Dermatol. 2019. PMID: 30571972 Free PMC article. No abstract available.
Estimating the relative risk of developing melanoma in INK4A carriers.
Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CB. Berwick M, et al. Among authors: orlow i. Eur J Cancer Prev. 2004 Feb;13(1):65-70. doi: 10.1097/00008469-200402000-00010. Eur J Cancer Prev. 2004. PMID: 15075790
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M; Genes Environment and Melanoma Study Group. Begg CB, et al. Among authors: orlow i. J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15. doi: 10.1093/jnci/dji312. J Natl Cancer Inst. 2005. PMID: 16234564 Free article.
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group. Berwick M, et al. Among authors: orlow i. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1520-5. doi: 10.1158/1055-9965.EPI-06-0270. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896043
CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. Orlow I, et al. J Invest Dermatol. 2007 May;127(5):1234-43. doi: 10.1038/sj.jid.5700689. Epub 2007 Jan 11. J Invest Dermatol. 2007. PMID: 17218939 Free article.
208 results